Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Epoetin Alfa in Treating Anemia in Patients With Solid Tumors
This study has been completed.
Study NCT00058331 Information provided by National Cancer Institute (NCI)
First Received: April 7, 2003 Last Updated: May 9, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Anemia
Leukemia
Lymphoma
Lymphoproliferative Disorder
Precancerous/Nonmalignant Condition
Additional conditions recognized in this trial
Disease
Lymphoma, Large-Cell, Immunoblastic
Lymphoma, Non-Hodgkin
Lymphoproliferative Disorders
Multiple Myeloma
Neoplasms
Neoplasms, Plasma Cell
Precancerous Conditions
More general conditions related to this trial
Blood Protein Disorders
Cardiovascular Diseases
Hematologic Diseases
Hemorrhagic Disorders
Hemostatic Disorders
Immune System Diseases
Immunoproliferative Disorders
Lymphatic Diseases
Neoplasms by Histologic Type
Paraproteinemias
Pathologic Processes
Vascular Diseases
Interventions listed in this trial
epoetin alfa
More general drug interventions related to this trial
Hematinics
Hematologic Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
North Central Cancer Treatment Group
National Cancer Institute (NCI)
Back to top of Main Content
